Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Gallwitz

Showing results (1-10 of 67) with videos related to

Pageof 7
Sort By:
Minerva Endocrinologica|May 10, 2006
Therapies for the treatment of type 2 diabetes mellitus based on incretin actionB Gallwitz
Der Internist|July 9, 2004
[Primary prevention of diabetes mellitus type 2]B Gallwitz
International Journal of Clinical Practice|November 18, 2006
Exenatide in type 2 diabetes: treatment effects in clinical studies and animal study dataB Gallwitz
Diabetes Technology & Therapeutics|August 27, 2005
Glucagon-like peptide-1 as a treatment option for type 2 diabetes and its role in restoring beta-cell massB Gallwitz
Diabetes, Obesity & Metabolism|December 31, 2013
The extra-pancreatic effects of GLP-1 receptor agonists: a focus on the cardiovascular, gastrointestinal and central nervous systemsJ Seufert, B Gallwitz
Der Internist|September 20, 2018
[Diabetes mellitus at the interface between pediatric and adult medicine]B Gallwitz, A Neu
MMW Fortschritte Der Medizin|June 17, 2014
[Insulin degludec--a new basal insulin for the treatment of type 1 and type 2 diabetes]B Gallwitz, T Haak
Diabetes, Obesity & Metabolism|October 1, 2009
Future perspectives for insulinotropic agents in the treatment of type 2 diabetes-DPP-4 inhibitors and sulphonylureasB Gallwitz, H-U Häring
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|October 27, 2004
Global risk management in type 2 diabetes: blood glucose, blood pressure, and lipids--update on the background of the current guidelinesA Clemens, E Siegel, B Gallwitz
Zeitschrift Fur Gastroenterologie|May 1, 1994
[Differential diagnosis of granulomatous diseases--epithelioid cell granuloma in the intestine and liver in Crohn disease?]B Gallwitz, U Jänig, U R Fölsch
Pageof 7

Showing results (1-10 of 67) with videos related to

Sort By:
Pageof 7
Minerva Endocrinologica|May 10, 2006
Therapies for the treatment of type 2 diabetes mellitus based on incretin actionB Gallwitz
Der Internist|July 9, 2004
[Primary prevention of diabetes mellitus type 2]B Gallwitz
International Journal of Clinical Practice|November 18, 2006
Exenatide in type 2 diabetes: treatment effects in clinical studies and animal study dataB Gallwitz
Diabetes Technology & Therapeutics|August 27, 2005
Glucagon-like peptide-1 as a treatment option for type 2 diabetes and its role in restoring beta-cell massB Gallwitz
Diabetes, Obesity & Metabolism|December 31, 2013
The extra-pancreatic effects of GLP-1 receptor agonists: a focus on the cardiovascular, gastrointestinal and central nervous systemsJ Seufert, B Gallwitz
Der Internist|September 20, 2018
[Diabetes mellitus at the interface between pediatric and adult medicine]B Gallwitz, A Neu
MMW Fortschritte Der Medizin|June 17, 2014
[Insulin degludec--a new basal insulin for the treatment of type 1 and type 2 diabetes]B Gallwitz, T Haak
Diabetes, Obesity & Metabolism|October 1, 2009
Future perspectives for insulinotropic agents in the treatment of type 2 diabetes-DPP-4 inhibitors and sulphonylureasB Gallwitz, H-U Häring
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|October 27, 2004
Global risk management in type 2 diabetes: blood glucose, blood pressure, and lipids--update on the background of the current guidelinesA Clemens, E Siegel, B Gallwitz
Zeitschrift Fur Gastroenterologie|May 1, 1994
[Differential diagnosis of granulomatous diseases--epithelioid cell granuloma in the intestine and liver in Crohn disease?]B Gallwitz, U Jänig, U R Fölsch
Pageof 7